SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD) Recombinant Protein | 10-121

SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD) Recombinant Protein | 10-121 | Gentaur UK, US & Europe Distribution

Tested Application: E, WB

Application: This recombinant protein can be used for WB. For research use only.

Tpredicted Molecular Weight: 132.29a

Physical State: Lyophilized

Buffer: PBS, pH 7.4

Storage Condition: This product is stable at ≤ ‑70˚C for up to 6 months from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

Alternate Name: 2019-nCoV spike protein, 2019-nCoV S glycoprotein, COVID-19 S protein, Spike glycoprotein, SARS-CoV-2 Spike

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: HEK293 cells

Species: SARS-CoV-2 (COVID-19) Spike Protein

By Source: Human Cells

By Species: Other

Fusion Tag: His tag at C-terminus

Sequence: Cys15-Gln1208 with mutation in the cleavage site (683 G)

Bological Activity: Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-COV-2 Spike S1+S2 ECD at 2μg/mL (100 μL/well) can bind Recombinant Human ACE2 with a linear range of 0.15-3.03 ng/mL

Purity: > 97% as determined by SDS-PAGE.